Reflections and Key Insights from ISPOR Europe 2024
The GIPAM leadership team recently came together to discuss the most impactful moments from ISPOR 2024. In this engaging sit-down, they share their perspectives on the event, delve into the themes shaping market access and real-world evidence, and look ahead to the innovations driving change in the industry.
Key Themes Covered:
Award-Winning Research: A closer look at one of our three posters that were ranked in the top 5% for scientific contribution at ISPOR EU and the impact it represents.
Joint Clinical Assessments (JCAs): Insights into the evolution of JCAs in Europe and their potential influence on the US market as well as key developments in the US market.
The Role of AI: How artificial intelligence, including our ANCHOR platform, is transforming evidence generation and decision-making.
Global Perspectives: Exploring differences between the US and European markets and how these shape strategic approaches.
Client Priorities: Why database studies and EVIGATOR captured the most attention at ISPOR, and how these tools address critical needs.
Featuring perspectives from:
Sabrina Müller, MD & VP GIPAM Europe
Jason Simeone, MD & VP GIPAM US
Thomas Wilke, Senior Scientific Lead GIPAM
Chiara Cochetti, VP Sales & Marketing GIPAM
Watch the full conversation to uncover the insights that will shape the future of market access and healthcare innovation.